Bell Potter update snip from yesterday
"Investment View: Retain Buy, Price Target $4.25
We conclude that the initial roll out of Technegas in the US is proceeding and expect
further announcements regarding subsequent contract signings in the short term. We
have updated the earnings forecast to modestly slow the roll out of Technegas flow
generators (FGs) as our previous forecast had underestimated the time taken to gain
Value Analysis Committee Approvals, therefore the company is unlikely to achieve 20
FG’s by 31 Dec 2023. The forecast now includes updated pricing assumptions and a
series of minor adjustments. We retain our Buy rating and drop the Speculative risk
warning. We retain our price target at $4.25."
- Forums
- ASX - By Stock
- CYC
- Ann: Cyclopharm Signs First USA Contract for Technegas
CYC
cyclopharm limited
Add to My Watchlist
0.00%
!
$1.00

Ann: Cyclopharm Signs First USA Contract for Technegas, page-15
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.00 |
Change
0.000(0.00%) |
Mkt cap ! $111.1M |
Open | High | Low | Value | Volume |
$1.00 | $1.01 | 99.0¢ | $70.22K | 70.31K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 23393 | 99.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.00 | 16508 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 23393 | 0.990 |
1 | 1016 | 0.985 |
4 | 7967 | 0.980 |
1 | 500 | 0.975 |
3 | 41241 | 0.970 |
Price($) | Vol. | No. |
---|---|---|
1.000 | 16508 | 2 |
1.020 | 3455 | 2 |
1.030 | 1210 | 2 |
1.040 | 3762 | 1 |
1.080 | 4000 | 2 |
Last trade - 14.13pm 18/06/2025 (20 minute delay) ? |
Featured News
CYC (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online